The overall objective of this contract is to develop and commercialize a rapid phenotypic antimicrobial susceptibility testing (AST) system that will deliver results for definitive therapeutic…
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00070
- Awardee
-
Beckman Coulter, Inc. UEI PU6HHX2R11C7 Part of Danaher Corporation
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $36,655,675
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 56% obligated
-
- $36,655,675.00 Current, with exercised options
- $65,183,092.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Sharing
- Place of performance
- West Sacramento, CA, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $21,655,675 | |
| Original award | $15,000,000 |
About this award
Beckman Coulter, Inc., a diagnostic equipment subsidiary of Danaher Corporation, was awarded a $65.2 million cost-sharing definitive contract by the Office of the Assistant Secretary for Preparedness and Response on September 30, 2022, to develop and commercialize a rapid phenotypic antimicrobial susceptibility testing (AST) system. The system is designed to deliver antimicrobial susceptibility results suitable for definitive therapeutic decisions within 4 to 6 hours from colonies on culture, significantly improving diagnostic speed compared to conventional laboratory methods. Performance will occur at the company's West Sacramento, California facility, with an ultimate completion date of May 20, 2028. The contract originated from a Biomedical Advanced Research and Development Authority (BARDA) pre-solicitation broad agency announcement posted in October 2017, which sought advanced research and development proposals for medical countermeasures against chemical, biological, radiological, nuclear, and pandemic threats, including diagnostics technologies advancing toward FDA approval or licensure.
This award carries no set-aside designation, indicating it was awarded through open competitive procurement. The cost-sharing arrangement reflects a collaborative development model typical of BARDA investments in next-generation medical diagnostic capabilities. Beckman Coulter's established federal presence in clinical laboratory diagnostics, evidenced by its extensive portfolio of microbiology testing contracts and diagnostic equipment agreements across the Veterans Health Administration and Defense Health Agency, positions the company to effectively execute this specialized development effort. The rapid AST capability being developed addresses a critical gap in clinical microbiology by reducing time to susceptibility results, thereby supporting faster informed treatment decisions in infectious disease management.
Description
The overall objective of this contract is to develop and commercialize a rapid phenotypic antimicrobial susceptibility testing (AST) system that will deliver results for definitive therapeutic decisions within 4 to 6 hours from colonies on a culture
Quick answers
Who was awarded contract 75A50122C00070?
75A50122C00070 was awarded to Beckman Coulter, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.
How much is contract 75A50122C00070 worth?
The government has obligated $36,655,675 on 75A50122C00070. Its potential value, with all options, is $65,183,092.
Was contract 75A50122C00070 competed?
The extent of competition for 75A50122C00070 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award